Lilly Novo Nordisk Fine: Two Stocks Riding GLP-1 Boom
The GLP-1 wave has traders buzzing. While Lilly and Novo Nordisk hold steady as reliable bets, smart portfolios tap i...
Index funds win long term largely because of lower costs and broad diversification. This brief introduces the cost advantage and payoff.
27,750 articlesThe GLP-1 wave has traders buzzing. While Lilly and Novo Nordisk hold steady as reliable bets, smart portfolios tap i...
A Danish study ties heavy chatbot use to worsening mental health symptoms among patients with psychosis, raising conc...
CFOs and boards are confronting a pivotal moment: how well they govern AI agents to protect value and manage risk. Th...
Bitcoin hovers near the $73,000 mark as Hormuz headlines dominate the weekend. This report explains how bitcoin will ...
A $50 million real estate deal nearly unraveled after both sides leaned on ChatGPT for pricing guidance. The episode ...
Sandisk's memory prices could double by 2027, but the stock market isn't only about future demand. This piece breaks ...
A newly released transcript sheds light on how an autopsy doctor hesitated before ruling a death, offering surprising...
Circle Internet Group posted a stronger-than-expected Q1 2026, triggering a 68% year-to-date gain and a rally that ou...
Two state proposals aim to tax moist snuff tobacco (MST) by weight rather than price or package size. This shift prom...
A new Harvard study shows the income needed to afford median-priced homes has nearly doubled since 2020, highlighting...
As the 2027 COLA comes into view, rising Medicare premiums threaten to erode any gains for many seniors. Here's what ...
A new AI benchmark exposes a troubling flaw: most models fail to detect nonsense in crypto prompts. This isn’t just t...